Accumulated genetic evidences indicate that the contactin associated protein-like (CNTNAP) family is implicated in autism spectrum disorders (ASD). In this study, we identified genetic mutations in the CNTNAP3 gene from Chinese Han ASD cohorts and Simons Simplex Collections. We found that CNTNAP3 interacted with synaptic adhesion proteins Neuroligin1 and Neuroligin2, as well as scaffolding proteins PSD95 and Gephyrin. Significantly, we found that CNTNAP3 played an opposite role in controlling the development of excitatory and inhibitory synapses in vitro and in vivo, in which ASD mutants exhibited loss-of-function effects. In this study, we showed that Cntnap3-null mice exhibited deficits in social interaction ， spatial learning and prominent repetitive behaviors. These evidences elucidate the pivotal role of CNTNAP3 in synapse development and social behaviors, providing the mechanistic insights for ASD.
Introduction
Autism spectrum disorder (ASD) is a prevalent neurodevelopmental disorder with early onset in the childhood, characterized by deficits in social behaviors and prominent repetitive behaviors. Numerous genes have been discovered to associate with ASD by human genetic studies(de la Torre-Ubieta et al., 2016; Huguet et al., 2013; Willsey and State, 2015) . Notably, it has been reported that mutations in genes encoding synaptic adhesion molecules, including neuroligin (NLGN) and neurexin (NRXN) family members, are closed related to ASD , which are often found in ASD patients, suggesting that the synaptic dysfunction significantly contribute to ASD(de la Torre-Ubieta et al., 2016; Huguet et al., 2013; Willsey and State, 2015) .
As a member of NRXN superfamily, the contactin associated protein-like (CNTNAP) family (also known as the CASPR protein family) has been identified to be associated with ASD, especially CNTNAP2 and CNTNAP4. The CNTNAP family contains 5 members from CNTNAP1 to CNTNAP5, featured by multiple repeats of epidermal growth factor (EGF) domains and laminin G (LamG) domains in the extracellular domains, as well as the intracellular PDZ-binding domain (Bellen et al., 1998; Peles et al., 1997; Spiegel et al., 2002; Traut et al., 2006) . CNTNAP1 and CNTNAP2 are involved in the formation of myelin and trafficking potassium channels of the cell membrane (Poliak et al., 2003; Rios et al., 2000; Traka et al., 2003) . Genetic studies suggested that the CNTNAP2 gene had strong connections with ASD (Alarcon et al., 2008; Arking et al., 2008; Bakkaloglu et al., 2008) . The CNTNAP2 protein plays a critical role in neural development and synaptic transmission. Furthermore, Cntnap2 null mice exhibited various autistic-like behaviors (Anderson et al., 2012; Penagarikano et al., 2011) . CNTNAP4 is fateful for the formation of axo-axonic synapse by interacting with Contactin5 in the peripheral nervous system (Ashrafi et al., 2014) . Whereas in the central nervous system, CNTNAP4 plays a vital part in regulating synaptic transmission of GABAergic neurons. Moreover, the Cntnap4 knockout mice also showed heavily stereotypic behaviors like self-grooming (Karayannis et al., 2014) .
The whole-genome sequencing of 476 autism families from the Simons Simplex Collection detected a stop-gain de novo mutation in CNTNAP3 (R1219X) in an ASD proband (Turner et al., 2017) . Notably, CNTNAP3 was also found to express differentially in the blood of individuals with autism (Kong et al., 2012) . Furthermore, a deletion of 9p12 which contains CNTNAP3 was found in the mental retardation (MR) patient (Mosrati et al., 2012) . Taken together, CNTNAP3 may be a candidate gene for autism spectrum disorders.
In this study, we identified genetic mutations in the CNTNAP3 gene through whole-exome sequencing in Chinese Han ASD cohorts and Simons Simplex Collections. To address molecular mechanisms underlying CNTNAP3 regulating synaptic development and social behaviors, we performed extensive molecular, physiological and genetic experiments. We found that CNTNAP3 interacted with critical synaptic adhesion molecules such as Neuroligin1 and Neurogligin2 proteins, as well as postsynaptic scaffolding protein PSD95 and Gephyrin. More importantly, our data demonstrated that CNTNAP3 played an opposite role in controlling development of excitatory and inhibitory synapses in vitro and in vivo, in which ASD mutants exhibited loss-of-function effects. Furthermore, Cntnap3 -/-mice exhibited deficits in social behavior, cognitive tasks and prominent repetitive behaviors, confirming the role of CNTNAP3 in ASD.
Results

Identification of CNTNAP3 mutations in ASD patients
In the whole-exome sequencing study of 120 ASD patients collected from Shanghai Mental Health Hospital (Wen et al., 2017) , we found two probands (ASD22, ASD652)
carrying the same inherited mutation (causing amino acid alternation P614A) in the CNTNAP3 gene, validated by Sanger sequencing (Fig. 1a, Supplementary Fig. 1a , d, e). We identified another proband featured "Human phenotype ontology (HPO):
autism" in the database of brain disorders patients in Fudan Children's Hospital of Shanghai, in which an inherited mutation (R786C) transmitted from the father in the CNTNAP3 gene were found, suggesting the connection between CNTNAP3 and ASD ( Fig. 1a, Supplementary Fig. 1b , f).
To determine whether CNTNAP3 mutations exist in ASD populations from different geographic regions, we next searched the Simons simplex collections (SSC) and found 2 ASD probands carrying R786H mutation in the CNTNAP3 gene, among 2600 ASD trios, both of which are inherited from unaffected mothers ( Supplementary   Fig. 1c ). In conclusion, there are 5 mutations of CNTNAP3 (G410S, P614A, R786C/H, R1219X) reported to be found in ASD patients yet, which caused 4 amino acid changes and one stop-gain de novo mutation (Vaags et al., 2012) . We further examined the mutation rates of CNTNAP3 mutations (G410S, P614A, R786C, R786H
and R1219X) in the gnomAD database (http://gnomad.broadinstitute.org). P614A, R786C and R1219X exhibited extremely low occurrence (less than 0.01%) in total 245686 populations of the gnomAD database, indicating that they are rare variants.
The R786H mutation occurs 0.012% in gnomAD database, which is still much lower than it in SSC (2/2600, 0.077%), suggesting the possible enrichment of R786H mutation in ASD cohorts. However, G410S exhibited high occurrence (3.7%) in total 276826 populations of the gnomAD database, indicating that G410S may be just a single-nucleotide polymorphism. The R786 locates in the LamG domains, P614 is within fibrinogen-related (FRed) domain, and R1219 locates in the link region before trans member domain (Fig. 1a ).
CNTNAP3 interacts with NLGNs and NRXNs
To investigate how CNTNAP3 participate in brain development, we first examined the expression profile of CNTNAP3 in developmental stages and various regions in the mouse brain via quantitative PCR (Fig. 1c, d ), due to lack of the suitable antibody against the mouse CNTNAP protein. We found that CNTNAP3 was highly expressed in cortex and hippocampus of the mouse postnatal brain (Fig. 1c, Supplementary Fig.   2a ) and had relative low expression levels in cerebellum and spinal cord (Fig. 1d) . We further performed in situ hybridization using probes against the mouse Cntnap3 gene together with immunostaining with various cell markers in cortex and hippocampus to characterize the expression pattern of CNTNAP3 in different neuronal cell types (Fig. 1e, Supplementary Fig. 2c ). Interestingly, we found that the majority (~70%) of CNTNAP3-expressing neurons were co-localized with vesicular glutamate transporter 1 (vGlut1) in cerebral cortex, whereas around 10% CNTNAP3-expressing neurons are parvalbumin (PV)-positive, indicating that CNTNAP3 is mainly expressed in glutamatergic neurons in cortex (Fig. 1f ).
CNTNAP3 has repeated LamG domains and EGF domains, as well as an intracellular PDZ-binding domain, which is structurally similar with NRXN superfamily proteins (Fig. 1a) , hence, we would like to determine whether CNTNAP3 interact with synaptic adhesion molecules, such as Neuroligin1 (NLGN1) , Neuroligin 2 (NLGN2) and synaptic scaffolding proteins. We constructed a plasmid expressing hemagglutinin (HA)-tagged full-length human CNTNAP3. To address which domain would be responsible for the interaction, we also made the plasmid expressing only one extracellular LamG domain and the intracellular PDZ-binding domain of CNTNAP3 protein (C3-LamG) (Fig. 1b) .
By the co-immunoprecipitation experiment, we found the CNTNAP3 interacted with both NLGN1 and NLGN2 (Fig, 1g, j) . Deletion of extracellular LamG domains (C3-LamG) significantly weaken, but not block the interaction, indicating that only one LamG domain is sufficient for the interaction between CNTNAP3 and NLGN1 or NLGN2 (Fig. 1h, k) . CNTNAP3 also interacted with synaptic scaffolding proteins, including PSD-95 and Gephyrin but not SHANK3 (Fig. 1i , l, Supplementary Fig. 3a ).
NLGN1 and PSD-95 primarily located in the post-synaptic compartment of excitatory synapse, whereas NLGN2 and Gephyrin localized in the inhibitory synapses, these evidences suggest that CNTNAP3 may exist in both excitatory and inhibitory synapses.
Among the 5 mutations, R1219X has almost all of the extracellular region but not trans member region or PDZ-binding domain. We presumed that R1219X cloud not interact with PSD-95 or Gephyrin because of the absent of PDZ-binding domain ( Fig.   1i , l), which suggested R1219X may be a loss of function mutation with the disability of recruiting scaffolding proteins.
CNTNAP3 regulates excitatory and inhibitory synapse development differentially
To assess the function of CNTNAP3 in synaptic development, we constructed a short hairpin RNA (shRNA) against the mouse Cntnap3 gene and confirmed the efficiency of down-regulating the endogenous expression level of Cntnap3 ( Supplementary Fig.   3b ). We next investigated whether the knockdown of Cntnap3 could affect neuronal morphology and synaptic development in cultured mouse primary neurons. We transfected GFP expressing plasmids, together with control vector, Cntnap3 shRNA, human WT CNTNAP3 cDNA as well as human CNTNAP3 cDNA carrying ASD-related mutations, respectively. Since mouse Cntnap3 shRNA does not target human CNTNAP3, human WT CNTNAP3 cDNA could serve as a rescue construct for shRNA knockdown. We found that knockdown of CNTNAP3 expression led to significantly decrease of axonal and dendritic length, as well as dendritic branch number ( Fig. 2a-c , Supplementary Fig. 4 ). It is worth noting that although human WT CNTNAP3 cDNA was able to fully restore axonal and dendritic length to normal level after shRNA knockdown, three ASD-related mutations (R1219X, P614A and R786C)
were not able to rescue defects caused by Cntnap3 shRNA, exhibiting loss-of-function effects (Fig. 2b , c, Supplementary Fig. 4b, d ). (Fig. 2d ). We found that knockdown of Cntnap3 led to decrease of excitatory synapse formation which were fully rescued by WT CNTNAP3, but not the R1219X, P614A and R786C mutants ( Fig. 2d, f) . Interestingly, inhibitory synapse numbers measured by anti-vGat staining were increased after knockdown of CNTNAP3, which could be fully rescued to normal level by WT and R786C, but not R1219X nor P614A mutant, suggesting that CNTNAP3 may play a negative role in repressing formation of inhibitory synapse and R1219X, P614A may exhibit loss-of-function effects in this regard (Fig. 2d, g ).
Furthermore, numbers of spine were also markedly decreased in the CNTNAP3 knockdown group, which were restored to the normal level when co-expressed with WT CNTNAP3, but not R1219X, P614A nor R786C mutants (Fig. 2e ). These evidences indicate that CNTNAP3 may promote excitatory glutamatergic synapse formation, whereas inhibit GABAergic synapse formation. Additionally, ASD-related mutations may exhibit loss-of-function effects regarding to excitatory and inhibitory synapses formation specifically.
CNTNAP3 regulates development of excitatory synapse and PV-positive inhibitory neurons in vivo
To address the role of CNTNAP3 in vivo, we constructed Cntnap3 region. Golgi staining showed that spine density of hippocampal CA1 and S1 neurons significantly decreased in Cntnap3 -/-mice in comparison with WT mice, suggesting that CNTNAP3 plays a critical role in excitatory synapse development in vivo (Fig, 3a, b). Next, we crossed Nex-Cre mice with Cntnap3 flox/flox mice to specifically delete Cntnap3 in excitatory neurons (Kashani et al., 2006) . In Nex-Cre: Cntnap3 flox/flox mice, spine density also dramatically decreased in hippocampal CA1 neurons comparing to WT mice, indicating that CNTNAP3 likely regulates development of excitatory synapse through cell-autonomous manner (Fig. 3c, d ).
Strikingly, we found that parvalbumin-positive GABAergic neurons markedly and 6). These data suggest that CNTNAP3 may specifically hamper development of PV-positive subtype of GABAergic neurons.
CNTNAP3 regulates excitatory and inhibitory synaptic transmission in vivo
To determine the role of CNTNAP3 in synaptic transmission in vivo, the whole-cell patch clamp recording was performed on the hippocampal CA1 neurons and layer 5 neurons of neocortex in acute slice preparations of Cntnap3 -/-mice and WT mice as control ( Fig. 4a ). We firstly measured passive electrical properties of these cells, including resting membrane potential (RMP), input resistance (Rin) and membrane capacity (Cm) ( These developmental changes may further shape properties of action potentials and membrane activities. We thus investigated the inward and outward current during the excitation of neurons evoked by a series of voltage pulses in cortical layer 5 and hippocampal CA1 neurons of Cntnap3 -/-and WT mice (Fig. 4e) . We found that amplitude of inward currents of both layer 5 and CA1 neurons significantly decreased in Cntnap3 -/-mice compared to those in WT mice (Fig. 4f) . The outward currents displayed the same tendency (Fig. 4g) . These results suggested that knockout of Cntnap3 altered excitability of cortical and hippocampal neurons. However, when we measured firing rate and amplitude of action potentials of cortical layer 5 and hippocampal CA1 neurons, we found that these properties were not influenced by knockout of Cntnap3 ( Supplementary Fig. 7a-f ). We reasoned that the altered excitability did not lead to change of fire rate may be due to the input of these neurons were also changed in the absence of Cntnap3.
Therefore, to elucidate the role of CNTNAP3 in synapse development, we further examine excitatory and inhibitory synaptic transmission in the hippocampal CA1 region of Cntnap3 -/-mice. We measured miniature excitatory postsynaptic currents (mEPSC) and miniature inhibitory postsynaptic current (mIPSC) in the presence of tetrodotoxin (TTX) in acute hippocampal slices of Cntnap3 -/-and WT mice ( Supplementary Fig. 7g , h, i). We found that the frequency, but not amplitude, of mEPSC significantly decreased in adult Cntnap3 -/-mice, in consistent with the observation of decreased excitatory synapse development in vitro and reduced spine density in vivo (Fig. 4i, j) . Interestingly, both amplitude and frequency of mIPSC significantly increased in the hippocampal CA1 region of adult Cntnap3 -/-mice, suggesting that numbers and strength of inhibitory synapses are both increased in
Cntnap3
-/-mice ( Fig. 4l, m) . We also measured mEPSC and mIPSC in adolescent mice from postnatal day 14 (P14) to 28 (P28) ( Supplementary Fig. 7h , i). The frequency of mEPSC in Cntnap3 -/-adolescent mice was significantly decreased (Supplementary Fig. 7j, k) , whereas the frequency of mIPSC was markedly increased (Supplementary Fig. 7l, m) . These results suggest that CNTNAP3 also play a pivotal role in regulating excitatory and inhibitory synaptic transmission in vivo. Taken together, these evidences indicate that CNTNAP3 regulates intrinsic neuronal excitability, as well as playing an opposite role in controlling development of excitatory and inhibitory synapses in vivo.
Defects in social interaction, repetitive behaviors and cognition in Cntnap3 -/-mice
Finally, we sought to determine whether deletion of Cntnap3 may lead to autistic-like behavioral abnormalities in mouse, although previous studies showed that Cntnap3 knockout mice exhibited the normal motor function and anxiety level (Hirata et al., 2016 Remarkably, in the three-chamber test, Cntnap3 -/-mice appeared no preference in staying with mouse over an empty cage, while still exhibited increased interaction time with novel mice over familiar mice, suggesting that Cntnap3 -/-showed defects in social interactions (Fig. 5a, b, Supplementary Fig. 8a-c) . Interestingly, we found that Nex-Cre: Cntnap3 flox/flox mice, specific deletion of Cntnap3 in excitatory neurons, showed no defects in recognizing either mice over cage, or novel over familiar mice (Fig. 5c, d , Supplementary Fig. 9a ). However, inhibitory neuron specific knockout mice, Vgat-ires-Cre: Cntnap3 flox/flox , exhibited defects in distinguishing novel mice with familiar mice, suggesting that Cntnap3 in inhibitory neurons may contribute to social memory (Fig. 5e, f, Supplementary Fig. 9b ).
Another phenotype of ASD patient is repetitive behaviors. Thus we measured the time which WT or Cntnap3 -/-mice spent to groom or dig in one hour within its home cage. We found that Cntnap3 -/-mice spent more time to self-groom or dig, which are considered to be repetitive behaviors (Fig. 5g , h, Supplementary Movie 1 and 2).
These results suggest that Cntnap3 -/-mice show the ASD-like behavior.
As the deletion of CNTNAP3 was found in the MR patient, we think that deletion of CNTNAP3 may lead to learning and memory disability, which is also an important accompanying phenotype of ASD. Next, we used the Barnes Maze test to examine whether Cntnap3 -/-mice may have defects in learning and memory tasks. First, we found that Cntnap3 -/-mice spent significantly longer time and more error holes to find the correct hole during the training session, suggesting that the learning ability in
Cntnap3
-/-mice was compromised (Fig. 5i, Supplementary Fig. 8d ). We then performed the short-term and long-term memory tasks at day 5 and day 12 after training, respectively. We found that Cntnap3 -/-mice spent markedly increased error holes and latency time in both memory tests, indicating the both short-and long-term memory capacity of Cntnap3 -/-mice are severely affected ( Fig. 5j -m, Supplementary   Fig. 8e ). We found no defects of Cntnap3 -/-mice in consequent series of tests, including elevated plus maze ( Supplementary Fig. 8f, g ), light/dark shuttling ( Supplementary Fig. 8h ), open field test ( Supplementary Fig. 8i , j), novel object recognition ( Supplementary Fig. 8k ), as well as context and cue-dependent fear conditioning ( Supplementary Fig, 8l , m, n). These data suggest that Cntnap3 -/-mice have specific defects related to social behaviors, repetitive behaviors, as well as learning and memory, but appeared normal levels of anxiety and fear conditioning responses.
In the excitatory neuron specific knockout mice (Nex-Cre: Cntnap3 flox/flox ) and inhibitory neuron specific knockout mice (Vgat-ires-Cre: Cntnap3 flox/flox ), we found similar defects in learning curve of the Barnes Maze test (Fig. 6a-d Fig. 9c-f ), or inhibitory neurons knockout mice ( Supplementary Fig. 10e-h ), suggesting that CNTNAP3 has no effects in regulating anxiety levels.
Discussion
We characterized critical functions of the synaptic adhesion molecule CNTNAP3 in synaptic development and transmission, as well as social behavior, repetitive behavior and cognitive tasks. The genetic connections between CNTNAP family and ASD are very intriguing over the years, as other synaptic adhesion molecules are implicated in ASD. R1219X was a stop-gain de novo mutations that was found in ASD patients, which indicated that CNTNAP3 might be a ASD candidate gene. In this study, we proved that R1219X could not interact with PSD-95 or Gephyrin, which were important scaffolding proteins in both excitatory synapses and inhibitory synapses.
Moreover, R1219X could not rescue the neuronal morphology and synaptic changes which caused by knocking down Cntnap3. These suggest that R1219X may be a loss-of-function mutation of CNTNAP3 due to losing the function of its trans member region and intracellular part. Additionally, we identified two transmitted mutations (P614A, R786C) in CNTNAP3 gene through whole-exome sequencing. Although neither mutation is a de novo mutation, we further addressed the functions of each mutations in regarding to synapse development and showed that they were indeed loss-of-function variants. But on the other hand, P614A and R786C are point mutations which only cause one amino acid mutation of CNTNAP3. Compairing with the stop-gain mutation of R1219X, the functional changes of P614A and R786C may be more lightly (Fig. 2g) . That might be one reason why the fathers who also have the mutation of P614A or R786C are not ASD patients. Our results could only reveal the function of these mutations in vitro. As the in vivo system is more complicated, the lightly changes must be accumulated or induced by some other factors, for instance, the environmental factors, and then caused the ASD. These data suggested that besides de novo mutations, transmitted variants in ASD patients could also significantly contribute to pathophysiology of ASD.
Although CNTNAP2 and CNTNAP4 are ASD candidate genes in previous genetic and functional studies, the detail function of CNTNAPs in synapse development is yet to be determined. The finding that CNTNAP3 has interactions with NLGN1/2 family members strongly suggests that CNTNAP3 is an important synaptic adhesion molecule that plays critical roles in regulating synapse development, as confirmed by our experiments (Chih et al., 2005; Varoqueaux et al., 2006) . Our data suggest that CNTNAP3 is an essential component of both excitatory synapse and inhibitory synapse. Further work is needed to determine the molecular mechanisms underlying the differentially regulatory function of CNTNAP3 in both excitatory and inhibitory synapses. The finding that CNTNAP3 regulates synapses development differentially provides novel insights for further understanding of the synapse basis for ASD.
Comparing with behavioral defects identified in Cntnap2 -/-and Cntnap4 -/-mice, we found rather specific defects in social behavior, repetitive behavior and cognitive tasks in Cntnap3 -/-mice, suggesting that CNTNAP3 may play a more specific role in regulating social interaction, repetitive behavior, as well as learning and memory in mice. Further work of determining specific neural circuits responsible for defects in social behavior and learning memory would be crucial to provide insights into neural circuits regulating different cognitive behaviors specifically.
Combined the genetic mutations we discovered in Chinese Han ASD and Simons simplex collections, as well as functional evidences in genetic engineered mice, we suggest that CNTNAP3 is an ASD candidate gene and the imbalance of excitatory and inhibitory synapse development caused by mutations of CNTNAP3 contribute to the abnormal social behavior, repetitive behavior and cognitive functions.
Materials and Methods:
Ethics statement
We Approved researchers can obtain the SSC population dataset described in this study (https://simons.wuxinextcode.com/csa/welcome ) by applying at https://base.sfari.org.
In situ hybridization. Neuron culture and calcium phosphate transfection Cultures were prepared from embryonic day 13.5 WT C57BL/6 mice. The cells form cortex were separated with papain (Worthington, LS003126) and then cultured in the Neurobasal medium (Gibco, 21103-049) with 0.2% B27 (Gibco, 17504-044).
The neurons were transfected on the day 5 by calcium phosphate transfection. 2μg of each plasmids was used to do the transfection. At the day 14, the neurons were collected to do the immunohistochemical staining.
Genetic engineered mice
Cntnap3 knockout and Cntnap3 conditional knockout mice were customized designed and ordered from Biocytogen.
Immunohistochemical staining:
For the cultured neurons, the neurons were fixed in 4% PFA at room temperature for 20 min before wash. The 1st antibody was incubated overnight at 4℃ and the 2nd
antibody was incubated at room temperature for 2 hours. For the brain slice, the slice was cut in 40μm. The 1st antibody was incubated overnight at 4℃ and the 2nd
antibody was incubated at room temperature for 2 hours. Antibodies used were as following:
GFP ( Images were obtained using a confocal microscope (Nikon TiE, Nikon A1R, Nikon NiE, Olympus FV10i)
Golgi Staining:
The FD Rapid GolgiStain Kit (FD neuro technologies, PK-401) was used for the Golgi staining. The mouse brains were put in the A&B mixed medium for 14 days and then in the solution C for 5 days. The slice was cut with 100μm. Images were obtained using a confocal microscope (Olympus FV1000).
Behavior test:
All the mice used in this study were male and handled for more than 3 days prior to behavioral tasks. The animals' movements were recorded and analysed by Ethovision XT software (Noldus, Wageningen, Netherlands). The equipment used in the behavior test was thoroughly cleaned with 75% isopropanol before each mouse was tested.
Open field:
The behavior was recorded for 30 min. The mouse was put in the 45cm×45cm box for free moving.
Elevated plus maze:
The plus maze with 2 close arms and 2 open arms was used in the experiment. The mouse was placed in the center of the maze with its head to the close arm to start the experiment and then recorded for 10 min.
Three chamber test:
The box with 3 chambers was used in the test. The test mouse was put in the center chamber for 3 times test (10 min each). For the first time, both sides of the chambers were empty. For the second time, one WT mouse was put in one random cage, the other cage was empty. For the last time, one stranger WT mouse was added to the leftover empty cage. In all of the 3 times of test, the test mouse was free moving. Only the mouse in the interaction zone (about 8cm beside the cage) was used as the interaction time.
Barnes maze:
A disc with 40 holes was used in the experiment. At the learning period, animals will receive 4 trials per day with an inter-trial interval of 15 minutes during 4 days. The short-term memory test was done on the day 5 and the long-term memory test done was on the day 12.
During the learning test, the time is 3 min, if the mouse failed to enter the escape cage;
we helped it enter the cage and recorded the latency time with 180s. At the memory test, the time is 90s without escape cage. During all of the test, we use glare as the stimulation.
The light and dark test
The box with 2 chambers was used in the test. One of the chamber was covered with a black plate which made the box inside dark, the other chamber was empty. The box was put under the light and the mouse was put into the dark part when the test started.
The time mouse spend in the light area was recorded in the 10 minutes test.
Novel object recognition
At the first test, two toys with the same size were put into the opposite sides of the open field box. The mouse was put in the center of the box for free moving in 10 minutes. At the second test, one of the toy was changed by a stranger toy. The time mouse spend with the stranger toy was recorded in the 10 minutes test.
Fear conditioning test.
0.8mA, 3 tries were used in the fear conditioning test. The freeze percentage was test in both contextual and cue fear. The voice was used only without shock was used in the extinction test.
Home cage video:
The mouse was put in the home cage 2 days before the video started. The video was recorded for 24hours. The first half hour after turn off the light and the half hour 6 hours after turn off the light were counted. All of the experiments were in the normal circadian rhythms (12h light and 12h dark).
The mouse CNTNAP3 RNAi sequence: Evoked EPSCs and IPSCs were recorded using record glass pipettes as above (5 to 7 MΩ) and were evoked using a concentric bipolar electrode (WPI; FHC, CBBEB75) which was used to stimulate neurons with a brief current pulse (50 ms), and the current pulse was delivered by a stimulus isolation unit (ISO-Flex,A.M.P.I., Jerusalem, Israel). Signals were filtered at 2 kHz and digitized at 100 kHz using Digidata 1440A (Molecular Devices). Data acquisition and slope measurement were carried out using Statistical significance was evaluated by one-way ANOVA, paired t test (3 chamber) or two-way ANOVA (curve): *p < 0.05, ** p < 0.01, *** p < 0.001, error bars, ± SEM.
